ERG (ETS transcription factor ERG) is a nuclear transcription factor located on chromosome 21 that functions as a master regulator of gene expression, particularly in endothelial and hematopoietic cells 1. ERG acts as a DNA-binding transcriptional activator that regulates genes involved in angiogenesis and lymphangiogenesis through direct transcriptional control and chr21 remodeling via SETDB1 recruitment 2. Specifically, ERG regulates lymphatic vessel specification genes including VEGFR3/FLT-4, LYVE-1, SOX-18, and PROX-1, with deficiency impairing wound healing-associated lymphangiogenesis 2. ERG's disease relevance is substantial. In prostate cancer, ERG-driven tumorigenicity depends on activation in specific basal cell populations and requires KMT2A and DOT1L histone methyltransferases 3. ERG translocations, particularly TMPRSS2:ERG fusions, occur in approximately 49% of European, 27% of Asian, and 25% of African descent prostate cancers 4. ERG also represses the LDB1 coactivator, disrupting transcriptional complexes that control developmental pathways 5. Additionally, ERG polymorphisms (rs2836411) associate with anemia susceptibility and aortic dissection risk 6. ERG is clinically valuable as an immunohistochemical marker for endothelial differentiation and identifies ERG-translocated malignancies including Ewing sarcoma and prostate carcinoma 1.